Approval · Notice of Compliance 37167 · 2025
YESINTEK: Notice of Compliance 37167
Issued October 17, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37167
- Date
- October 17, 2025
- Company
- Biosimilar Collaborations Ireland LimitedDublin, Ireland
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Canadian reference product
- STELARA & STELARA I.V.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| YESINTEK | 02562081 | Marketed |
| YESINTEK | 02562103 | Marketed |
| YESINTEK | 02566478 | Approved |
| YESINTEK I.V. | 02562111 | Marketed |
Medicinal ingredients
- USTEKINUMAB 45 MG per 0.5ML
- USTEKINUMAB 90 MG per ML
- USTEKINUMAB 130 MG per 26ML